Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Portal   Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA


OLGA KAGAN WEINBERG

Department of Pathology Bader 126.2, Boston Children’s Hospital, 300 Longwood Avenue,
Boston, MA 02115
olga.weinberg@childrens.harvard.edu

Education
2000     BA with Honors     Geophysical Science      University of Chicago
2006     MD Medicine         Vanderbilt University School of Medicine

Postdoctoral Training
July, 2006 - July, 2008    Resident             Anatomic Pathology      Stanford University
July, 2008 - July, 2009    Clinical Fellow   Surgical Pathology          Stanford University
July, 2009 - July, 2010    Clinical Fellow   Hematopathology          Stanford University

Faculty Academic Appointments
=2013-2015         Instructor          Pathology          Harvard Medical School
2015-now          Assistant Professor        Pathology          Harvard Medical School

Appointments at Hospitals/Affiliated Institutions
November, 2010-2013  University Pathologists Hematopathologist, Director of flow cytometry and hematology laboratory Pathology  Roger Williams Medical Center
January, 2013- Present Director of Hematopathology and Flow cytometry, Pathology  Boston Children’s Hospital
January, 2013- Present Staff Hematopathologist  Pathology   Brigham and Women’s Hospital

Other Professional Positions:
2013-    Consultant in Pathology, University Pathologists
2014-    Consultant, Myelofibrosis clinical trial (Promedior)

Major Administrative Leadership Positions
Local:
2013-    Director of Hematopathology   Boston Children’s Hospital, Pathology Department, Boston, MA
2013-    Director of Flow Cytometry Lab Boston Children’s Hospital, Pathology Department, Boston, MA
2018-    HMS CME ‘Current Concepts in Hematopathology’        Co-Course Director

National:
2016-2017         Society of Hematopathology (SH), Chicago; September 7-9, 2017 Co-Organizer of SH workshop entitled, “Molecular Genetics of Hematopoietic Neoplasms”
2018     Society of Hematopathology Companion Meeting at USCAP March 2018, Co-Organizer “New and Updated Entities in the Revised WHO Classification”
2018     American Society of Clinical Pathologyn October 2018n Co-Director “Recognition of Hematolymphoid Neoplasms with Germline Predisposition in Clinical Practice”
2018     American Society of Clinical Pathology October 2018, Co-Director “Sheep in Wolves’ Clothing: Mimics of Myeloid Neoplasms"

International:
2019-2021         United States and Canadian Academy of Pathology       Co-Director “Recognition of Hematolymphoid Neoplasms with Germline Predisposition in Clinical Practice”
2019-2021         United States and Canadian Academy of Pathology       Co-Director “The Pathologist’s Guide to Cytopenias: Context, the Genes, and Everything”

Professional Societies

2010-    United States and Canadian Academy of Pathology Member
2010-    Society of Hematopathology Member
2010-    College of American Pathologists Member
2010-    International Clinical Cytometry Society Member
2018-    European Bone Marrow Working Group Member
2018-    Bone Marrow Pathology Working Group Member (Invited member)

Committee work

2017     Society of Hematopathology     Education Committee, Case of the quarter subcommittee
2017     United States and Canadian Academy of Pathology, Abstract Review Board in the Hematopathology category
2018 European Bone Marrow Working Group            Poster review committee
2018     NCI Clinical Trials Working Group                         Steering committee reviewer
2018     Boston Children’s Hospital Virtual Committee     

Appointments approval
2019-2021         International Clinical Cytometry Society              Education committee member
2019-2021         International Society for Laboratory Hematology              Molecular committee member

Editorial Activities
=merican Journal of Hematology
International Journal of Laboratory Hematology
Journal of Hematopathology
Lab Medicine
Blood
Modern Pathology

Other Editorial Roles
2014     Editorial Board American Journal of Hematology
2018     Editorial Board International Journal of Laboratory Hematology

Honors and Prizes
June, 1996 - June, 2000 Phi Beta Kappa   University of Chicago   Academic Achievement
September, 2001 - June, 2003   Thomas Brown McClelland Scholarship  Vanderbilt University School of Medicine Academic Achievement
June, 2002 - June, 2006 Microbes and Defense Honor Society Vanderbilt University School of Medicine Academic Achievement
June, 2004- June, 2005 Howard Hughes Research Training Medical Student Fellowship  Vanderbilt University School of Medicine Academic Achievement

Report of Local Teaching and Training
Teaching of Students in Courses

August, 1999 - June, 2000, Teaching Assistant, Dept of Biology, Taught the laboratory portion of the following courses: Biochemistry, Genetics and Natural science 101           University of Chicago, Chicago, Illinois                                          
July, 2000 - July, 2001    Implemented America Reads tutoring program Recruited, hired and trained over 60 college students to become America Reads tutors , Served as a liaison between elementary schools and colleges to ensure that the program ran smoothly         AmeriCorps VISTA                                                                          
January, 2013 - 2015     HMS Hematology Course (hands on microscope session)              Harvard Medical School Boston, MA 
January 2016-present   IN757.HEM Human Systems: Hematology (hands on microscope session)      Harvard Medical School Boston, MA 
January, 2018-present  HMS: Immunology         Harvard Medical School Boston, MA
March 2019-present      HMS: Homeostasis I Blood and Bone Marrow Pathology Lab   Harvard Medical School Boston, MA 

Clinical Supervisory and Training Responsibilities
November, 2010 - January, 2013            Taught Hematology/Oncology fellows at RWMC approach to reading of bone marrows Roger Williams Medical Center, Providence, RI    
January, 2013 - Present Taught Hematology/Oncology fellows at BCH approach to reading of bone marrows and peripheral blood    Boston Children’s Hospital Boston, MA 
January, 2013 - Present Taught pediatric pathology fellows in hematopathology          Boston Children’s Hospital Boston, MA 

Formally Supervised Trainees
2014-2015         Karen Chisholm, MD, PhD/ Anatomic Pathologist, Clinical Assistant Professor, University of Washington
Supervised her during her pediatric hematopathology training at BCH and presented and published abstract entitled, “Primary Lymphoma of Bone in the Pediatric Population.” Society of Pediatric Pathology, March 21 – 22, 2015, Boston, MA.  This project was published in Hum Pathol. 2017 Feb;60:1-10
2016-2017         Bradford Siegele, MD/ Pathologist, Massachusetts General Hospital
Supervised him during his pediatric pathology training at BCH and presented and published abstract entitled, “Pediatric myelodysplastic syndrome:  Clinical features, genetics, and classification under the 2016 WHO revision in a cohort of 72 patients”
2017-2018         Kate Dannheim, MD/ Pathologist, Beth Israel Deaconess Medical Center
Supervised her during her pediatric hematopathology training at BCH and presented and published abstract and paper entitled, “Immunophenotypic Dysplasia and Frequent T-cell Antigen Expression in Acute Myeloid Leukemia with Complex Karyotype and TP53 Mutations.” This project as published in J Clin Pathol. 2018 Dec;71(12):1051-1059.
2017-2018         Christopher Hergott, MD/ Pathologist, Brigham and Women’s Hospital
Supervised him during his hematopathology training at BWH and presented and published abstract entitled, “Prevalence of Bacterial Contamination among Excised
Lymph Nodes and Implications for Molecular Testing.”
2017-2019         Sanjay Patel, MD/ Pathologist, Brigham and Women’s Hospital
Supervised him during his pediatric hematopathology training at BCH and BWH and presented numerous projects including “Clinical Impacts of Co-Occurring Mutations in De Novo Acute Myeloid Leukemia with Mutated NPM1.”  This work was published as a full manuscript in Blood. 2018 Jun 21;131(25):2816-2825 and won both Benjamin Castleman award at USCAP 2019 and David Mason award at Society of Hematopathology 2018.  Most recent project ‘Clinicopathologic and Genetic Characterization of Non-Acute NPM1-Mutated Myeloid Neoplasms’ was presented at USCAP 2019 as a platform and accepted to Blood Advances. Sanjay will be an attending Pathologist at Cornell starting July 2019.
2018-2019         Madhu Ouseph, MD/ Pathologist, Brigham and Women’s Hospital
Supervised him during his hematopathology training at BCH and BWH and presented and published abstract entitled, “Genomic alterations in patients with mosaic loss of the Y chromosome in bone marrow cells”.  This was presented as a platform at USCAP 2019

Local Invited Presentations
01/28/2014       BCH Dept of Laboratory Medicine: Flow cytometry in diagnosis of pediatric hematolymphoid malignancies
09/28/2014       Roger Williams Medical Center:  Updates in classification of acute leukemias
10/06/2015       BCH Dept of Laboratory Medicine: Pathologic diagnosis of hematologic malignancies in children, adolescents and young adults
02/12/2016       BWH Dept of Pathology: Surgical Pathology Update, “Classification in Acute Leukemias.”
4/9/2019            U Mass Lab Medicine conference, “Flow cytometry in diagnosis of hematologic malignancies.”

Regional Invited Presentations
10/11/2017       Updates in classification of acute leukemias/ Grand Rounds University of Vermont, Burlington, VT
3/5/2018            Recognition of hematolymphoid neoplasms with germline predisposition in clinical practice. Rhode Island Society of Pathologists
4/19/2018         Updates in classification of acute myeloid leukemia. Brown University/Rhode Island Hospital Dept. of Pathology National Invited Presentations
9/7/2017            Germline predisposition syndromes in Myeloid malignancies: Society of Hematopathology workshop Session Summary Chicago, IL
10/4/17              Improving MDS Outcomes from Diagnosis to Treatment: A Multidisciplinary Approach/ Invited participant Boston, MA
11/13/17            Updates in classification of acute leukemias/ Grand Rounds Nationwide Children’s Hospital, Columbus, OH
11/28/17            Updates in classification of acute myeloid leukemia/ Grand Rounds Weill Cornell Medicine, New York, NY
4/24/2018         Updates on classification in acute leukemias. American Society of Clinical Laboratory Science-Central New England. 70th Annual Clinical Laboratory Science Convention, Providence, RI
12/4/2018         Updates in Classification of Acute Leukemias/Grand Rounds Children’s Hospital of Los Angeles, Los Angeles, CA
12/7/2018         Updates in Classification of Acute Myeloid Leukemias Lurie Children’s Hospital of Chicago, Chicago, IL
12/17/2018       Updates in Classification of Acute Leukemias/Grand Rounds University of Pittsburgh, Pittsburgh, PA
4/17/2019         Lineage determination in acute leukemias/ Grand RoundsChildren’s Hospital of Philadelphia, Philadelphia, PA
5/9/19  Flow Cytometry in Hematolymphoid Neoplasms ASCLS-CNE Clinical Laboratory Science Convention

International Invited Presentations
10/2/18              19th Meeting of the European Association for Haematopathology Edinburgh, Scotland, UK Chair of session ‘The impact of intrinsic and extrinsic factors in site specific lymphoproliferations”.
4/11/19-4/14/19            XIV EBMWG International Course & Workshop on Bone Marrow Pathology, Frankfurt, Germany Primer for diagnosing cytopenia - practical guidelines for diagnosing myelodysplasia and reactive mimickers.

Report of Clinical Activities and Innovations
Current Licensure and Certification
2009     American Board of Pathology (Anatomic Pathology)
2010     Massachusetts Board of Medicine
2010     Connecticut Board of Medicine
2010     Rhode Island Board of Medicine
2010     American Board of Pathology (Hematology)     

Practice Activities
2010-2013         Hematopathology          Roger Williams Medical Center 48 weeks per year
2013-    Hematopathology          Boston Children’s Hospital        20 weeks per year
2013-    Hematopathology          Brigham and Women’s  Hospital            14 weeks per year

Report of Scholarship
Publications
Peer reviewed publications in print or other media
Research Investigations
1. Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 2005 May-Jun;70(5-7):372-81.
2. Weinberg OK, Marquez-Garban DC, Fishbein, MC, Goodglick L, Dubinett S, Pietras RJ. Aromatase Inhibitors in Human Lung Cancer Therapy. Cancer Research 2005 Dec 15;65(2 4):11287-91.
3. Sartippour MR, Pietras RJ, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour D, Zhang L, Lu M, Weinberg OK, Rao JY, Brooks MN.  The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 2006 December 27(12): 2424-33.
4. Weinberg OK, Ai WZ, Mariappan R, Shum C, Levy R and Arber DA ’Minor’ BCL2 Breakpoints in Follicular Lymphoma: Frequency and Correlation with Grade and Disease Presentation in 236 Cases. Journal of Molecular Diagnostics 2007 Sep;9(4):530-7.
5. Weinberg OK, Seo K, Arber DA Prevalence of bone marrow involvement in systemic anaplastic large cell lymphoma: Are immunohistochemical studies necessary?  Human Pathology 2008 Sep;39(9):1331-40.
6. Weinberg OK, Ma L, Seo K, Beck AH, Pai RK, Morales A, Kim Y, Sundram U, Tan D, Horning SJ, Hoppe RT, Natkunam Y, Arber DA.  Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.  American Journal Surgical Pathology 2009 Apr;33(4):591-8.
7. Weinberg OK, Seetharam M, Ren L, Seo K, Ma L, Merker JD, Gotlib J, Zehnder JL, Arber DA. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.  Blood 2009 Feb 26;113(9):1906-8. 
8. Ahn JY, Seo K, Weinberg OK, Boyd SD, Arber DA. A comparison of two methods for screening CEBPA mutations in patients with acute myeloid leukemia. Journal of Molecular Diagnostics 2009 Jul;11(4):319-23
9. Mattsson G, Turner SH, Cordell J, Ferguson DJ, Schuh A, Grimwade LF, Bench AJ, Weinberg OK, Marafioti T, George TI, Arber DA, Erber WN, Mason DY. Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia? Haematologica 2010 Apr;95(4):670-3.
10. Ohgami RS, Ma L, Ren L, Weinberg OK, Seetharam M, Gotlib JR, Arber DA.  DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups.  Br J Haematol. 2012 Oct;159(2):182-90
11. Ahn JY, Seo K, Weinberg OK, Arber DA.  The prognostic value of CXCR4 in acute myeloid leukemia.  Appl Immunohistochem Mol Morphol. 2013 Jan;21(1):79-84.
12. Weinberg OK, Ohgami RS, Ma L, Seo K, Ren L, Gotlib JR, Seetharam M, Cherry A, Arber DA.  Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings.  Am J Clin Pathol. 2014 Aug;142(2):190-5
13. Weinberg OK, Seetharam M, Ren L, Alizadeh A, Arber DA Mixed phenotype acute leukemia (MPAL): A study of 61 cases using WHO and EGIL criteria  Am J Clin Pathol. 2014 Dec;142(6):803-8.
14. Forester C, Sartain S, Guo D, Harris MH, Weinberg OK, Fleming MD, London WB, Williams DA, Hofmann I.  Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors.  Am J Hematol. 2015 Apr;90(4):320-6.
15. Johnson RC, Weinberg OK, Cascio MJ, Dahl GV,  Mitton BA, Silverman LB, Cherry A, Arber DA, and Ohgami RS.  Cytogenetic variation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) – a multi-institutional series review. Am J Clin Pathol. 2015 Jul;144(1):103-12.
16. Weinberg OK, Pozdnyakova O, Campigotto F, DeAngelo DJ, Stone RM, Neuberg D, Hasserjian RP. Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia. Mod Pathol. 2015 Jul;28(7):965-76.
17. Weinberg OK, Ma L, Hoppe RT, Arber DA. Biological characterization of stage I follicular lymphoma according to extranodal or nodal primary origin and t(14;18) status using high-resolution array-based comparative genomic hybridization. Am J Hematol. 2015 Aug;90(8):E151-2.
18. Weinberg OK, Rodig SJ, Pozdnyakova O, Ren L, Arber DA, Ohgami RS  Surface Light Chain expression in Primary Mediastinal Large B-cell Lymphomas by Multiparameter Flow Cytometry.  Am J Clin Pathol. 2015 Oct;144(4):635-41.
19. O'Neill AF, Adil EA, Irace AL, Neff L, Davis IJ, Perez-Atayde AR, Voss SD, Weinberg O, Rahbar R. Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management. Int J Pediatr Otorhinolaryngol. 2016 Jul;86:218-23.
20. Bernasconi-Elias P, Hu T, Jenkins D, Firestone B, Gans S, Kurth E, Capodieci P, Deplazes-Lauber J, Petropoulos K, Thiel P, Ponsel D, Hee Choi S, LeMotte P, London A, Goetcshkes M, Nolin E, Jones MD, Slocum K, Kluk MJ, Weinstock DM, Christodoulou A, Weinberg O, Jaehrling J, Ettenberg SA, Buckler A, Blacklow SC, Aster JC, Fryer CJ. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies. Oncogene. 2016 Nov 24;35(47):6077-6086.
21. Weinberg OK, Hasserjian RP, Li B, Pozdnyakova O. Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category. J Clin Pathol. 2017 Feb;70(2):109-115.
22. Chisholm KM, Ohgami RS, Tan B, Hasserjian RP, Weinberg OK. Primary lymphoma of bone in the pediatric and young adult population. Hum Pathol. 2017 Feb;60:1-10.
23. Weinberg OK, Sohani AR, Bhargava P, Nardi V.  Diagnostic work-up of acute myeloid leukemia.  Am J Hematol. 2017 Mar;92(3):317-321.
24. Lee WY, Weinberg OK, Pinkus GS. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages. Am J Clin Pathol. 2017 Apr 1;147(4):420-426.
25. Weinberg OK, Gibson CJ, Blonquist TM, Neuberg D, Pozdnyakova O, Kuo F, Ebert BL, Hasserjian RP. NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO Classification. Am J Hematol. 2017 Jul;92(7):E123-E124.
26. Cubria P, Hernández M, Romero L, Ellis A, Escamilla G, Vega L, Friedrich P, Lehmann L, Garay S, Aguilar D, Gasperin G, Tsitsikov E, and Weinberg O. DFCI/BCH-HITO quality improvement project for hematologic malignancies: implementation and validation of MRD by flow cytometry in pediatric acute leukemia treatment protocols. Blood Advances  2017  1:77-79.
27. Lee WY, Weinberg OK, Evans AG and Pinkus GS. Loss of full-length GATA1 expression in megakaryocytes is a sensitive and specific immunohistochemical marker for the diagnosis of myeloid proliferative disorder related to Down syndrome. Am J Clin Pathol. 2018 Mar 7;149(4):300-309.
28.  Khajuria RK, Munschauer M, Ulirsch JC, Fiorini C, Ludwig LS, McFarland SK, Abdulhay NJ, Specht H, Keshishian H, Mani DR, Jovanovic M, Ellis SR, Fulco CP, Engreitz JM, Schütz S, Lian J, Gripp KW, Weinberg OK, Pinkus GS, Gehrke L, Regev A, Lander ES, Gazda HT, Lee WY, Panse VG, Carr SA, Sankaran VG. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell. 2018 Mar 22;173(1):90-103.e19.
29. Weinberg OK, Gibson CJ, Blonquist TM, Neuberg D, Pozdnyakova O, Kuo F, Ebert BL and Hasserjian RP. Association of mutations with morphologic dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities Haematologica. 2018 Apr;103(4):626-633.
30. Li Y, Weinberg OK. Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to composite diffuse large b-cell lymphoma and hodgkin lymphoma: a case report and review of literature. Human Pathology: Case Reports - September 21, 2018
31. Tsitsikov E, Harris MH, Silverman LB, Sallan SE, Weinberg OK. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia. Int J Lab Hematol. 2018 Jun;40(3):343-351.
32. Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP, Chen YBA, Fathi AT, Graubert TA, Brunner AM, Wadleigh M, Stone RM, DeAngelo DJ, Nardi V, Hasserjian RP, Weinberg OK. High NPM1 mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML. Blood. 2018 Jun 21;131(25):2816-2825.
33. Kurzer J and Weinberg OK.  Identification of Early B-cell Precursors (Stage 1 and 2 Hematogones) in the Peripheral Blood.  J Clin Pathol. 2018 Sep;71(9):845-850.
34.  Tang G, Sydney Sir Philip JK, Weinberg OK, Tam W, Sadigh S, Lake JI, Margolskee EM, Rogers HJ, Miranda RN, Bueso-Ramos C C, Hsi ED, Orazi A, Hasserjian RP, Arber DA, Bagg A, Wang SA. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.  Mod Pathol. 2018 Nov 6. doi: 10.1038
35. Matte A, Recchiuti A, Federti E, Koehl B, Mintz T, El Nemer W, Tharaux PL, Brousse V, Andolfo I, Lamolinara A, Weinberg OK, Siciliano A, Norris PC, Riley IR, Iolascon A, Serhan CN, Brugnara C, De Franceschi L.  Resolution of sickle cell disease associated inflammation and tissue damage with 17R-Resolvin D1.  Blood. 2018 Nov 7. pii: blood-2018-07-865378. doi: 10.1182/blood-2018-07-865378.
36. Mi X, Griffin G, Lee W, Patel S, Ohgami R, Ok CY, Wang S, Geyer JT, Xiao W, Roshal M, Garcia JS, Silverman LB, Sallan SE, Aster JC, Harris MH, Weinberg OK. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. Am J Hematol. 2018 Nov;93(11):1358-1367.
37. Dannheim KC, Pozdnyakova O, Dal Cin P, Weinberg OK.  Immunophenotypic dysplasia and aberrant T-cell antigen expression in acute myeloid leukaemia with complex karyotype and TP53 mutations.  J Clin Pathol. 2018 Dec;71(12):1051-1059.
38. Matte A, Recchiuti A, Federti E, Koehl B, Mintz T, El Nemer W, Tharaux PL, Brousse V, Andolfo I, Lamolinara A, Weinberg O, Siciliano A, Norris PC, Riley IR, Iolascon A, Serhan CN, Brugnara C, De Franceschi L. Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. Blood. 2019 Jan 17;133(3):252-265.
39. Tang G, Sydney Sir Philip JK, Weinberg O, Tam W, Sadigh S, Lake JI, Margolskee EM, Rogers HJ, Miranda RN, Bueso-Ramos C C, Hsi ED, Orazi A, Hasserjian RP, Arber DA, Bagg A, Wang SA. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study. Mod Pathol. 2019 Apr;32(4):490-498.
40. Weinberg OK, Hasserjian RP,  Baraban E, Ok CY, Geyer JT, J Philip JKSS, Kurzer JH, Rogers HJ, Nardi V, Stone RM, Garcia JS, His ED, Bagg A, Wang SA, Orazi A, Arber DA. Clinical, immunophenotypic and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: A study from the bone marrow pathology group. Mod Pathol. 2019 Apr 18. doi: 10.1038/s41379-019-0263-3. [Epub ahead of print]
41. Soma S, Kovach AE, Siddon AJ, Beck R,  Gibson SE, Swerdlow SH, Kim AS, Wu D, Jones D, Cook JR, Prakash S, Rosado F, Crane G, Bradley K,  Weinberg OK,  Sargent RL. Molecular and Cytogenetic

Education in Hematopathology Fellowship:
Proceedings from the Society for Hematopathology, 2018 Program Directors Meeting Am J Clin Pathol. 2019 May 29. pii: aqz048. doi: 10.1093/ajcp/aqz048.
42. Weinberg OK, Kuo F, Hasserjian R.  Introduction: 2017 SH/EAHP workshop reportAm J Clin Pathol. 2019 May 29. pii: aqz047. doi: 10.1093/ajcp/aqz047.
43. Weinberg OK, Kuo F, Calvo K. Germline Predisposition to Hematolymphoid Neoplasia:  2017 SH/EAHP Workshop Report AJCP in press.
44. Patel SP, Ho C, Ptashkin RN, Sadigh S, Bagg A, Geyer JT, Xu ML, Prebet T, Mason EF, Seegmiller AC, Morgan EA, Steensma DP, Winer ES, Wong WJ, Hasserjian RP,  Weinberg OK. Clinicopathologic and Genetic Characterization of Non-Acute NPM1-Mutated Myeloid Neoplasms. Blood Adv. 2019 May 14;3(9):1540-1545.
45. Hasserjian RP, Kelley TW, Weinberg  OK, Morgan EA, Fend F.  Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias):  2017 Society of  Hematopathology/European Association of Haematopathology Workshop Report.  AJCP in press.
46. Pellin D, Loperfido M, Cristina Baricordi C, Wolock SL, Montepeloso A, Weinberg OK, Biffi A, Klein AM and Biasco L.  The single-cell transcriptional landscape 1 of human hematopoietic progenitors.  Nature communications Nat Commun. 2019 Jun 3;10(1):2395
47. Patel SS, Pinkus GS, Ritterhouse LL, Segal JP, Dal Cin P, Restrepo T, Harris MH, Stone RM, Hasserjian RP, Weinberg OK.  High NPM1 Mutant Allele Burden at Diagnosis Correlates with Minimal Residual Disease at First Remission in De Novo AML.  Am J Hematol. 2019 May 31. doi: 10.1002/ajh.25544.

Non-peer reviewed scientific or medical publications/materials in print or other media
Chapters in Books:
1. Morgan EA, Weinberg OK. Chapter 18: Hematolymphoid Tumors of the Oral Cavity. In Woo, S-B. “Oral Pathology: A Comprehensive Atlas and Text” Second Edition. Elsevier, Philadelphia, PA. 2017.
2. Weinberg OK. Chapter 17: Mixed Phenotype Acute leukemia in book ‘Precision Molecular Pathology of Myeloid Neoplasms” Springer, New York City, NY. 2018.
3. Kurzer J and Weinberg OK. Chapter 3: Post Therapy Marrow Changes in “Atlas of Bone Marrow Pathology” Springer, New York City, NY. 2018.
4. Weinberg OK, Hasserjian R. Myelodysplastic Syndromes. In “Diagnostic Bone Marrow Hematopathology.” Cambridge University Press, Cambridge, United Kingdom.
5. Dannheim K, Weinberg O. Acute Myeloid Leukemia in “Clinical Flow Cytometry: Approaches, Principles, and Applications”, Nova Science Publishers, Inc.

Book:
1. urzer J, Weinberg O ed. “Clinical Flow Cytometry: Approaches, Principles, and Applications”, Nova Science Publishers, Inc.

Review articles
1. Pietras RJ, Weinberg OK. Antiangiogenic Steroids in Human Cancer Therapy. Evidence Based Complementary and Alternative Medicine 2005 Mar;2(1):49-57
2. Weinberg OK, Marquez-Garban DC, Pietras RJ. New Approaches to Reverse Resistance to Hormonal Therapy in Human Breast Cancer.  Drug Resistance Updates 2005 Aug;8(4):219-33
3. Weinberg OK, Arber DA.  Acute myeloid leukemia with myelodysplasia-related changes. Current Concepts in Hematopathology: Applications in Clinical Practice, an Issue of Surgical Pathology Clinics. 
4. Weinberg OK, Arber DA.  Mixed-phenotype acute leukemia: historical overview and a new definition.  Leukemia 2010 Nov;24(11):1844-51
5. Weinberg OK and Hasserjian RP. The Current Approach to the Diagnosis of Myelodysplastic Syndromes. Semin Hematol. 2019 Jan;56(1):15-21.
6. Daneshbod Y, Kohan L, Taghadosi V, Weinberg OK, Arber DA. Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia. Curr Treat Options Oncol. 2019 Feb 11;20(2):15.
7. Kurzer J. and Weinberg O. Acute Leukemias of Ambiguous Lineage: clarification on lineage specificity. Surgical Pathology Clinics on Hematopathology, in press

Abstracts, Poster Presentations and Exhibits Presented at Professional Meetings
1. Tran UL, Kagan O, Yang H, Shen DJ, Wang MX.  “Preoperative predictive factors influencing the clinical outcome of LASIK after  penetrating keratoplasty”, Poster presentation, Arvo conference, 2002
2. Fishbein MC, Goodglick L, Mah V, Seligson M,  Márquez-Garbán DC, Weinberg OK, Reckamp K, Figlin R, Pietras RJ “Targeting Estrogen and Growth Factor Signaling Pathways for Therapeutic Intervention in Human Non-Small Cell Lung Cancer” Presentation, Lung Spore, 2005.
3. Marquez-Garban D.C., Chen H.W., Weinberg O.K., Fishbein, M.C. and Pietras R.J. “Palmitoylation and membrane association of estrogen receptors in human breast and non-small cell lung cancer cells” Poster presentation at the 2005 Annual ENDO meeting.
4. Weinberg OK, Marquez-Garban DC, Fishbein MC, Pietras RJ. “Aromatase Inhibitors in Human Lung Cancer Therapy” Poster presentation at the 2005 Annual Meeting of the American Society of Clinical Oncology, published in Proceedings of the American Association for Cancer Research, 2005, volume 46, page 951
5. Weinberg OK, Merker J, Beck AH, Seetharam M, Gotlib J, Zehnder J, Arber DA.  “Significance of NPM1 and FLT3 Mutations in Acute Myeloid Leukemia with Multilineage Dysplasia: Does NPM1 Identify a Lower Risk Group?”  Poster presentation at the 2008 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract # 1283, published in Modern Pathology 2008:21, p 281A
6. Weinberg OK, Beck AH, Pai R, Tan D, Horning S, Hoppe R, Natkunam Y, Arber DA  “Extranodal Low Stage Follicular Lymphoma: A Clinicopathological, Immunohistochemical and Molecular Comparison to a Low Stage Nodal Follicular Lymphoma.”  Platform presentation at the 2008 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1284, published in Modern Pathology 2008:21, p 281A
7. Weinberg OK, Seetharam M, Ren L, Ma L, Seo K, Merker J, Gotlib J, Zehnder J, Arber DA  “Acute Myeloid Leukemia with Myelodysplasia-Related Changes as Defined by the 2008 WHO Classification System” Platform presentation at the 2009 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1315, published in Modern Pathology 2009:22, p 291A
8. Weinberg OK, Ma L, Seo K, Hoppe R, Arber DA  “Biological Characterization of Stage I Follicular Lymphoma According to Extranodal or Nodal Primary Origin and t(14;18) Status Using High-Resolution Array-Based Comparative Genomic Hybridization (aCGH).”  Poster presentation at the 2009 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1316, published in Modern Pathology 2009:22, p 291A
9. Weinberg OK, Seetharam M, Ren L, Ma L, Seo K, Gotlib J, Zehnder J, Arber DA “Acute Myeloid Leukemia (AML) with Monosomal Karyotype Is Characterized by Absence of NPM1 and FLT3 Mutations, Worse Clinical Outcome and Usually Falls within AML with Myelodysplasia-Related Changes (MRC)” Platform presentation at the 2010 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1463, published in Modern Pathology 2010:23, p 328A
10. Place AE, Stevenson KE, Harris MH, Weinberg OK, Vrooman LM, Hunt SK, Ahmed S, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJG, Asselin B, Neuberg DS, Sallan SE, Silverman LB.  Outcome of childhood T-cell acute lymphoblastic leukemia (T-ALL): Results from DFCI protocol 05-001.  J Clin Oncol 32:5s, 2014 (suppl; abstr 10015)
11. Lee W, Weinberg, O, Pinkus, G. Immunohistochemical Profile of GATA-1 in Acute Leukemia and Other Hematologic Disorders. Modern Pathology. Feb 2015; 28 (Supplement 2s) United States & Canadian Academy of Pathology 104th Annual Meeting Abstracts: 358A.
12. Weinberg O, Pozdnyakova O, Campigotto F, DeAngelo D, Stone R, Neuberg D, Hasserjian R. Reproducibility and Prognostic Significance of Morphologic Dysplasia in De Novo AML. Modern Pathology. Feb 2015; 28 (Supplement 2s) United States & Canadian Academy of Pathology 104th Annual Meeting Abstracts: 385A.
13. K Chisholm, RS Ohgami, B Tan, RP Hasserjian, OK Weinberg. Abstract #2. Primary Lymphoma of Bone in the Pediatric Population. Published on Society for Pediatric Pathology Annual Meeting online, March 2015.
14. Weinberg O, Hasserjian RH, Li B, Pozdnyakova O.  Assessment of Myeloid And Monocytic Dysplasia by Flow Cytometry in De Novo AML Helps Define an AML with Myelodysplasia- Related Changes Category.  Modern Pathology. Feb 2016; 28 (Supplement 2s) United States & Canadian Academy of Pathology 104th Annual Meeting Abstract 1512: 383A.
15. Weinberg O, Gibson CJ, Pozdnyakova O, Kuo FC, Ebert B, Hasserjian RJ Both Mutations and Morphology Independently Predict Prognosis in De Novo AML with Intermediate-Risk Karyotype  Modern Pathology Feb 2017; 28 (Supplement 2s)  United States & Canadian Academy of Pathology 106th Annual Meeting Abstract 1542: 385 Platform presentation
16. Lee W, Weinberg O, Evans A, Pinkus G.  Diagnostic Utility of GATA1 Immunohistochemistry in the Assessment of Myeloid Proliferations Related to Down Syndrome Modern Pathology Feb 2017; 28 (Supplement 2s)  United States & Canadian Academy of Pathology   106th Annual Meeting page 359  Abstract 1439
17. Weinberg O, Gibson CJ, Pozdnyakova O, Kuo FC, Ebert B, Hasserjian RJ Specific Dysplastic Findings Correlate with Gene Mutations in De Novo AML Feb 2017; 28 (Supplement 2s)  United States & Canadian Academy of Pathology 106th Annual Meeting Abstract 1542: 385
18. Siegele, B, Chisholm, K, Hoffman, I, Hasserjian, R, Weinberg, O. “Pediatric Myelodysplastic Syndrome: Clinical features, genetics, and classification under the 2016 WHO revision in a cohort of 72 patients.” Platform Presentation at Society for Pediatric Pathology Spring Meeting, San Antonio, TX. 2017.
19. Cubria P, Hernández M, Romero L, Ellis A, Escamilla G, Vega L., Friedrich P. Lehmann L. Garay S, Aguilar D, Gasperin G, Tsitsikov E, Weinberg O. DFCI/BCH-HITO Quality improvement project for Hematologic Malignancies: Implementation and Validation of MRD by Flow Cytometry  in Pediatric Acute Leukemias Treatment Protocols. ASH Annual Meeting 2017. Atlanta GA
20. Rodig NR, Pinkus G, Gonzalez GR , Agur T, Weinberg OK. Programmed Cell Death Ligand 1 (PD-L1) Expression is Associated with Subtypes of Post-Transplant Lymphoproliferative Disorders (PTLD). 2018 American Transplant Congress (ATC) at the Washington State Convention Center, Seattle, WA
21. Craig JW, Hergott CB, Weinberg OK. Prevalence of Bacterial Contamination among Excised
Lymph Nodes and Implications for Molecular Testing. USCAP 2018 Annual Meeting, Vancouver, Canada.
22. Patel SS, Kuo F, Hasserjian RP, Weinberg OK. Clinical Impacts of Co-Occurring Mutations in De Novo Acute Myeloid Leukemia with Mutated NPM1. USCAP 2018 Annual Meeting, Vancouver, Canada.
23. Dannheim KC, Pozdnyakova O, Weinberg OK. Immunophenotypic Dysplasia and Frequent T-cell Antigen Expression in Acute Myeloid Leukemia with Complex Karyotype and TP53 Mutations. USCAP 2018 Annual Meeting, Vancouver, Canada.
24. Weinberg O, Patel SS, Siegele BJ, Kim A. RIT1 Variants Are Uncommon In Myeloid Neoplasms But Associated With High Risk Features. USCAP 2018 Annual Meeting, Vancouver, Canada.
25. Kurzer JH. Weinberg OK. Identification of Early Hematogones in the Peripheral Blood. USCAP 2018 Annual Meeting, Vancouver, Canada.
26. Dannheim K., Tsitsikov E, Weinberg OK. Validation of a single tube for minimal residual disease detection of B lymphoblastic leukemia on the BD FACSLyric. 33rd Annual Clinical Cytometry Meeting and Course, International Clinical Cytometry Society 2018, Portland, Oregon
27. Weinberg OK, Hasserjian RP, Baraban E, Ok CY, Geyer JT, Philip JKSS, Kurzer JH, Rogers HJ, Stone RM, Garcia JS, His ED, Bagg A, Wang SA, Orazi A, Arber DA. Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group. ASH 2018 Annual Meeting, San Diego, CA.
28. Dannheim K, Tsitsikov E, Aster J, Dorfman D, Morgan E, Garcia J, Place AE, Weinberg O. Genetic and Immunophenotypic Differences between Acute Leukemias with Expression of T-Cell and Myeloid Markers and Correlation with Minimal Residual Disease. Poster presentation at the 2019 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1273, published in Modern Pathology 2019:32, Supplement 2; p 36.
29. Ouseph M, Nardi V, Steensma D, Lovitch S, Hasserjian R, Dal Cin P, Weinberg O. Genomic alterations in patients with mosaic loss of the Y chromosome in bone marrow cells. Platform presentation at the 2019 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1351, published in Modern Pathology 2019:32, Supplement 2; p 109.
30. Patel S, Ho C, Sadigh S, Bagg A, Geyer J, Xu M, Mason E, Morgan E, Steensma D, Winer E, Hasserjian R, Weinberg O. Clinicopathologic and Genetic Characterization of non-AML NPM1-Mutated Myeloid Neoplasms. Platform presentation at the 2019 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1357, published in Modern Pathology 2019:32, Supplement 2; p 113.
31. Patel S, Pinkus G, Ritterhouse L, Segal J, Restrepo T, Harris M, Dal Cin P, Hasserjian R, Weinberg O. Correlation of high NPM1 mutant allele burden at diagnosis with minimal residual disease in de novo AML. Poster presentation at the 2019 Annual Meeting of the United States and Canadian Academy of Pathology, Abstract #1358, published in Modern Pathology 2019:32, Supplement 2; p 114.



Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA